Non-Invasive Measures of Distal Lung Disease in Asthmatics

This study has been completed.

First Received: November 4, 2005 Last Updated: March 31, 2008 History of Changes

Sponsored by:	Teva Global Respiratory Research LLC
Information provided by:	Teva Global Respiratory Research LLC
ClinicalTrials.gov Identifier:	NCT00250341

Purpose

This is a Phase 4, single center study conducted in mild-to moderate asthmatics.

Condition	Intervention	Phase
Asthma	Drug: QVAR	Phase IV

Study Type:	Interventional
Study Design:	Treatment, Randomized, Double-Blind, Active Control, Parallel Assignment

Resource links provided by NLM:

MedlinePlus related topics: Asthma

Further study details as provided by Teva Global Respiratory Research LLC:

Primary Outcome Measures:

Detailed Description:

The study consists of 3 phases. There are 7 study visits.

Eligibility

Criteria

Inclusion Criteria:

Exclusion Criteria:

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00250341

Locations

United States, California
UCLA
Los Angeles, California, United States, 90095

Sponsors and Collaborators

Teva Global Respiratory Research LLC

Investigators

Principal Investigator:

Michelle Zeidler, MD

University of California, Los Angeles

More Information

No publications provided

Study ID Numbers:	IXR-403-4-196
Study First Received:	November 4, 2005
Last Updated:	March 31, 2008
ClinicalTrials.gov Identifier:	NCT00250341 History of Changes
Health Authority:	United States: Institutional Review Board

Study placed in the following topic categories:

Lung Diseases
Beclomethasone
Asthma

ClinicalTrials.gov processed this record on September 10, 2009